Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy is a research paper published in Journal for ImmunoTherapy of Cancer (2023). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Association for Cancer Research
Grant: AACR-KURE IT (grant no. N/A)
National Human Genome Research Institute (NHGRI) Large Scale Sequencing Program
Grant: U54 HG003067
National Institutes of Health
Grant: R35 CA197633
Lundbeck Foundation
Grant: R307-2018-3636
Herlev and Gentofte Hospital Research Council
Grant: Clinician-Scientist Grant (grant no. N/A)
Danish National Board of Health
Grant: 05-0400-18
Danish National Board of Health
Grant: 05-0400-50
FWCI
1.96
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals